Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Elekta AB (publ)

Market Cap 1.99TCr 211.62Cr 182.77Cr 168.43Cr 157.66Cr 295.46Cr 20TCr 300.03Cr 775.39Cr 9.79TCr 794.2Cr 777.29Cr 34TCr P/E Ratio 2026
-39.2x
P/E Ratio 2027 * 13.9x
Enterprise Value 2.39TCr 254.4Cr 219.72Cr 202.47Cr 189.53Cr 355.18Cr 24TCr 360.68Cr 932.14Cr 12TCr 954.75Cr 934.43Cr 41TCr EV / Sales 2026
1.41x
EV / Sales 2027 * 1.35x
Free-Float
94.03%
Yield 2026
4.51%
Yield 2027 * 4.74%
Manager TitleAgeSince
Chief Executive Officer - 01/09/2025
Director of Finance/CFO - 01/03/2026
Investor Relations Contact - 01/12/2023
Director TitleAgeSince
Director/Board Member 69 30/06/2010
Director/Board Member 70 15/09/2011
Chairman 74 03/09/2013
Change 5-day change 1-year change 3-year change Capi.($)
+1.08%-0.08% - - 208.42Cr
-1.33%-2.63%+13.05%-9.43% 18TCr
-0.45%-1.85%-21.31%+31.43% 15TCr
-0.38%-3.50%-12.03%-23.48% 13TCr
-0.55%-3.97%-52.81%-8.52% 7.01TCr
-0.76%-2.68%+12.77%+1.20% 4.94TCr
+0.67%-0.06%-25.59%-33.84% 4.42TCr
+0.22%-6.16%+8.45%+12.13% 3.66TCr
-1.17%-5.56%+2.74%+42.62% 3.53TCr
+1.04%+2.15%-11.20%-15.46% 2.93TCr
Average -0.09%-2.17%-9.55%-0.37% 7.95TCr
Weighted average by Cap. -0.51%-2.08%-9.04%-0.86%

Financials

2026 2027 *
Net sales 1.7TCr 180.54Cr 155.94Cr 143.7Cr 134.51Cr 252.07Cr 17TCr 255.98Cr 661.53Cr 8.35TCr 677.58Cr 663.16Cr 29TCr 1.74TCr 185.44Cr 160.16Cr 147.59Cr 138.15Cr 258.9Cr 18TCr 262.91Cr 679.46Cr 8.58TCr 695.94Cr 681.13Cr 30TCr
Net income 85Cr 9.04Cr 7.81Cr 7.2Cr 6.74Cr 13Cr 859.31Cr 13Cr 33Cr 418.26Cr 34Cr 33Cr 1.45TCr 143.83Cr 15Cr 13Cr 12Cr 11Cr 21Cr 1.45TCr 22Cr 56Cr 708.04Cr 57Cr 56Cr 2.45TCr
Net Debt 402.03Cr 43Cr 37Cr 34Cr 32Cr 60Cr 4.07TCr 61Cr 156.75Cr 1.98TCr 160.55Cr 157.13Cr 6.85TCr 365.01Cr 39Cr 34Cr 31Cr 29Cr 54Cr 3.69TCr 55Cr 142.31Cr 1.8TCr 145.76Cr 142.66Cr 6.22TCr
Logo Elekta AB (publ)
Elekta AB (publ) is a Sweden-based medical technology company which aims to improve, prolong and save lives through clinical solutions for treating cancer and brain disorders. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. Elekta AB (publ) develops clinical treatment solutions for radiation therapy and radiosurgery, as well as work flow-enhancing software systems, across the spectrum of cancer care. The Company provides clinical solutions for image guided radiation therapy and stereotactic radiosurgery, giving oncologists and neurosurgeons an unmatched capability to treat tumors and functional targets with ultra-high precision while sparing healthy tissue.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!